US Patent No: 7,910,128

Number of patents in Portfolio can not be more than 2000

Use of a mixture of two or more enteric materials to regulate drug release via membrane or matrix for systemic therapeutics

Stats

ALSO PUBLISHED AS: 20040142035
ATTORNEY / AGENT: (SPONSORED)
 

Importance

Loading Importance Indicators... loading....

Abstract

Disclosed are pharmaceutical compositions, particularly oral dosage forms, which comprise two or more enteric coating materials, either as a coating or as part of a matrix dosage form, and methods of making and using the same. The compositions are characterized by having a sustained release profile at lower pH and an accelerated dissolution profile at higher pH.

Loading the Abstract Image... loading....

First Claim

Related Publications

Loading Related Publications... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
SUPERNUS PHARMACEUTICALS, INCROCKVILLE, MD43

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chang, Rong-Kun Rockville, MD 33 187
Shah, Niraj Mountain View, CA 20 31

Cited Art

Patent Info (Count) # Cites Year
 
ACTAVIS GROUP HF (1)
2005/0163,842 Rosiglitazone and metformin formulations 1 2004
 
FOURNIER LABORATORIES IRELAND LIMITED (1)
2006/0134,196 Formulation comprising fenofibric acid, a physiologically acceptable salt or derivative thereof 9 2003
 
KLINGE PHARMA GMBH, BERG-AM-LAIM-STRASSE 129, D-8000 MUNCHEN 80 (1)
4,980,170 Pharmaceutical formulation as well as a process for its preparation 43 1989
 
LIPOCINE INC. (1)
2003/0180,352 Solid carriers for improved delivery of active ingredients in pharmaceutical compositions 35 2002
 
PFIZER INC. (1)
6,068,859 Controlled-release dosage forms of Azithromycin 45 1996
 
RANBAXY LABORATORIES LIMITED (1)
6,565,877 Taste masked compositions 4 2000
 
VALEANT INTERNATIONAL BERMUDA (1)
6,893,661 Controlled release formulations using intelligent polymers 3 1998
 
OTHER [CHECK PATENT PROFILE FOR ASSIGNMENT INFORMATION] (2)
2004/0023,848 Compositions for the treatment, prevention, and diagnosis of gastrointestinal and other infections 1 2003
2005/0271,708 Palatable controlled-release formulation for companion animals 1 2005

Patent Citation Ranking

Forward Cites

  • No Forward Cites to Display

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Sep 22, 2014
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 22, 2018
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 22, 2022
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00